Cover Image
市場調查報告書

基因學的全球市場 - 至2022年的趨勢與預測:各產品、技術 (定序、微陣列、PCR)、流程、用途、地區

Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022

出版商 MarketsandMarkets 商品編碼 294503
出版日期 內容資訊 英文 220 Pages
訂單完成後即時交付
價格
Back to Top
基因學的全球市場 - 至2022年的趨勢與預測:各產品、技術 (定序、微陣列、PCR)、流程、用途、地區 Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022
出版日期: 2017年10月06日 內容資訊: 英文 220 Pages
簡介

基因學市場,至2022年達到238億8,000萬美元,2017年∼2022年以10.2%的年複合成長率成長。主要的成長推動因素,是政府的投資、津貼、資金的增加,研究的高漲,新興企業的增加,診斷的基因序列測定法的增加。

本報告提供全球基因學市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球基因學市場概要
  • 全球基因學市場:各產品與服務
  • 全球基因學市場:各技術
  • 全球基因學市場:各流程
  • 基因學市場各地區分析:各用途
  • 基因學市場各地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 全球基因學市場:各產品與服務

  • 簡介
  • 設備/系統
  • 消耗品
  • 服務

第7章 全球基因學市場:各技術

  • 簡介
  • 定序
  • 微陣列技術
  • PCR (聚合酵素鏈鎖反應)
  • 核酸提取、純化
  • 其他

第8章 全球基因學市場:各流程

  • 簡介
  • 定序
  • 程序庫調整
  • 資料分析

第9章 全球基因學市場:各用途

  • 簡介
  • 診斷
  • 藥物研發、新藥的開發
  • 精密醫療
  • 農業、動物研究
  • 其他

第10章 全球基因學市場:各終端用戶

  • 簡介
  • 研究中心,學術機構,政府機關
  • 醫院、診療所
  • 製藥、生物科技企業
  • 其他

第11章 全球基因學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭情形

  • 市場佔有率分析

第13章 企業簡介 (概要,產品與服務,財務,策略,發展等)

  • ILLUMINA
  • AGILENT TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC
  • EUROFINS SCIENTIFIC
  • QIAGEN
  • GE HEALTHCARE
  • F. HOFFMANN-LA ROCHE
  • OXFORD NANOPORE TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • BGI
  • EPPENDORF
  • PACIFIC BIOSCIENCES OF CALIFORNIA
  • DANAHER

第14章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2209

"Genomics market is projected to grow at a CAGR of 10.2%"

The global genomics market is estimated to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 23.88 billion in 2022 from 14.71 billion in 2017. The key factors driving the growth of the overall genomics market include the growing demand for rise in research activities in the field of genomics; increasing number of start-up companies; and increasing application of genomic sequencing in the diagnostics, personalized medicine, growing investments, grants, and funds by the government;. However, the high costs of genomic sequencing instruments/systems are expected to restrain the growth of this market to a certain extent during the forecast period.

"The services segment is projected to grow at the highest CAGR during the forecast period"

Based on products and services, the genomics market is segmented into instruments/systems, consumables and services. During the forecast period, the services segment is expected to grow at the highest CAGR. The increasing awareness of genomics and reducing DNA sequencing costs are expected to drive the growth of the segment.

"The diagnostics segment is projected to grow at the highest CAGR during the forecast period"

Based on application, the genomics market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications such as biofuels, marine research and coal mines. During the forecast period, the diagnostics market is poised to grow at the highest CAGR. Owing to the growing applications of genomics in the diagnosis of various rare and infectious diseases this segment is expected to grow during the forecast period.

"The hospitals and clinics are projected to grow at the highest CAGR during the forecast period"

Based on end user, the genomics market is segmented into research centres, academic and government institutes, hospital and clinics, pharmaceutical and biotechnology companies, and other end users such as NGO's. During the forecast period, hospitals and clinics are anticipated to grow at the highest CAGR. Factors driving the growth of this segment are the increasing demand for growing availability of genetic tests, pharmacogenomics, and rising emphasis on providing personalized medicine in hospitals.

"North America to witness the highest growth during the forecast period"

North America is expected to grow at the highest CAGR in the global genomics market during the forecast period of 2017-2022. The new pan - Canadian program, Research grants and funding by the government institutes in the US, and the US Precision Medicine Initiative are expected to drive the market growth during the forecast period.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1: 56%, Tier 35%, and Tier 9%
  • By Designation - C-level: 27%, Director Level: 15%, Others: 58%
  • By Region - North America: 38%, Europe: 23%, Asia-Pacific: 25%, RoW: 15%

The various players in the Genomics market include QIAGEN (Netherlands), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Agilent Technologies, (US), Illumina (US), Pacific Biosciences of California (US), Eurofins Scientific (Germany), , BGI (China), GE Healthcare (UK), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), and Eppendorf (Germany) among others.

Research Coverage:

The report analyzes the genomics market and aims at estimating the market size and the future growth potential of this market based on various segments such as product and services, technology, process, application, end user and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global genomics market
  • Product and Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global genomics market
  • Market Development: Comprehensive information about the lucrative emerging markets by product and services, technology, process, application, end user and region
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global genomics market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and services of leading players in the market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY RESEARCH
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
  • 2.3. PRIMARY RESEARCH
    • 2.3.1. KEY INDUSTRY INSIGHTS
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. KEY INSIGHTS FROM PRIMARY SOURCES
  • 2.4. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.5. MARKET FORECAST METHODOLOGY
  • 2.6. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.7. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GENOMICS: MARKET OVERVIEW
  • 4.2. GENOMICS MARKET, BY PRODUCT AND SERVICE, 2017 VS. 2022, (USD BILLION)
  • 4.3. GENOMICS MARKET, BY TECHNOLOGY, 2017 VS. 2022
  • 4.4. GENOMICS MARKET, BY PROCESS, 2017 VS. 2022, (USD BILLION)
  • 4.5. GENOMICS MARKET, BY APPLICATION, 2017 VS. 2022(USD BILLION)
  • 4.6. GEOGRAPHIC ANALYSIS OF THE GENOMICS MARKET, BY END USER, 2017 VS. 2022
  • 4.7. GEOGRAPHIC SNAPSHOT OF THE GENOMICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising government funding and growth in the number of genomics projects
      • 5.2.1.2. Decreasing sequencing costs
      • 5.2.1.3. Growing application areas of genomics
      • 5.2.1.4. Entry of new players and start-ups in the genomics market
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of equipment used in genomics
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Use of genomics in specialized/personalized medicine
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Dearth of trained professionals
      • 5.2.4.2. Secure storage of large volumes of sequenced data

6. GLOBAL GENOMICS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. INSTRUMENTS/SYSTEMS
  • 6.3. CONSUMABLES
  • 6.4. SERVICES

7. GLOBAL GENOMICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SEQUENCING
  • 7.3. MICROARRAY
  • 7.4. PCR
  • 7.5. NUCLEIC ACID EXTRACTION AND PURIFICATION
  • 7.6. OTHER TECHNOLOGIES

8. GLOBAL GENOMICS MARKET, BY PROCESS

  • 8.1. INTRODUCTION
  • 8.2. SEQUENCING
  • 8.3. LIBRARY PREPARATION
  • 8.4. DATA ANALYSIS

9. GLOBAL GENOMICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIAGNOSTICS
    • 9.2.1. CANCER DIAGNOSTICS
    • 9.2.2. MONOGENIC (MENDELIAN) DISORDERS
    • 9.2.3. OTHER DIAGNOSTIC APPLICATIONS
      • 9.2.3.1. Common diseases and complex disorders
      • 9.2.3.2. Movement disorders
      • 9.2.3.3. HIV
  • 9.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.4. PRECISION MEDICINE
  • 9.5. AGRICULTURE & ANIMAL RESEARCH
  • 9.6. OTHER APPLICATIONS

10. GLOBAL GENOMICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
  • 10.3. HOSPITALS AND CLINICS
  • 10.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.5. OTHER END USERS

11. GLOBAL GENOMICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
      • 11.2.1.1. Research grants and funding by government institutes
      • 11.2.1.2. Precision medicine initiative
      • 11.2.1.3. Growing focus of industry players in the US market
      • 11.2.1.4. Increasing use of GM crops
    • 11.2.2. CANADA
      • 11.2.2.1. Availability of research funding in Canada
      • 11.2.2.2. GAPP to intensify R&D in genomics
      • 11.2.2.3. Rising incidence of cancer in Canada
  • 11.3. EUROPE
    • 11.3.1. UK
      • 11.3.1.1. Increased funds and grants by government bodies
      • 11.3.1.2. 100,000 genome project
    • 11.3.2. GERMANY
      • 11.3.2.1. Availability of funding for life science research
      • 11.3.2.2. Presence of a large number of academic institutes
    • 11.3.3. FRANCE
      • 11.3.3.1. Increasing government investments in genomics
      • 11.3.3.2. Introduction of non-invasive prenatal testing in France
    • 11.3.4. ROE
      • 11.3.4.1. Growing research investments in Sweden & Denmark
  • 11.4. ASIA PACIFIC
    • 11.4.1. CHINA
      • 11.4.1.1. Government initiatives to improve healthcare sector in China
      • 11.4.1.2. Efforts of BGI to boost the Chinese genomics market
    • 11.4.2. INDIA
      • 11.4.2.1. Emergence of local players in India backed by government funding
      • 11.4.2.2. Increasing support for biotech start-ups
    • 11.4.3. JAPAN
      • 11.4.3.1. Increasing government focus on cancer research
    • 11.4.4. REST OF ASIA PACIFIC
      • 11.4.4.1. Strategic alliances and partnerships in the Australian market
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. MIDDLE EAST AND AFRICA
      • 11.5.1.1. Genetic testing and genomic analysis in the Middle East
      • 11.5.1.2. Rising prevalence of HIV and cancer in Africa
    • 11.5.2. LATIN AMERICA
      • 11.5.2.1. Increasing government funding in Brazil
      • 11.5.2.2. Conferences & workshops in Brazil

12. COMPETITIVE LANDSCAPE

  • 12.1. MARKET SHARE ANALYSIS

13. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 13.1. ILLUMINA
  • 13.2. AGILENT TECHNOLOGIES
  • 13.3. THERMO FISHER SCIENTIFIC
  • 13.4. EUROFINS SCIENTIFIC
  • 13.5. QIAGEN
  • 13.6. GE HEALTHCARE
  • 13.7. F. HOFFMANN-LA ROCHE
  • 13.8. OXFORD NANOPORE TECHNOLOGIES
  • 13.9. BIO-RAD LABORATORIES
  • 13.10. BGI
  • 13.11. EPPENDORF
  • 13.12. PACIFIC BIOSCIENCES OF CALIFORNIA
  • 13.13. DANAHER

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS
  • 14.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GENOMICS MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 2: GENOMICS INSTRUMENTS/SYSTEMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 3: GENOMICS CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 4: GENOMICS SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 5: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 6: GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: GENOMICS MARKET FOR MICROARRAYS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: GENOMICS MARKET FOR PCR, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 12: GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: GENOMICS MARKET FOR LIBRARY PREPARATION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: GENOMICS MARKET FOR DATA ANALYSIS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 16: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: GENOMICS MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 22: GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: GENOMICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 33: US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 34: US: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 35: US: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 36: US: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 37: US: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 38: INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2014
  • TABLE 39: CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 40: CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 41: CANADA: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 42: CANADA: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 43: CANADA: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 44: CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD IN EUROPE
  • TABLE 45: EUROPE: GENOMICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 50: EUROPE: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 51: UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 52: UK: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 53: UK: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 54: UK: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: UK: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 56: GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 58: GERMANY: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 59: GERMANY: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: GERMANY: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 62: FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 63: FRANCE: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 64: FRANCE: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: FRANCE: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 67: ROE: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 68: ROE: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 69: ROE: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 70: ROE: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 73: ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA PACIFIC: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 75: ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 76: ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 77: CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 78: CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 79: CHINA: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 80: CHINA: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 81: CHINA: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: INDIA: GENOMICS MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 83: INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 84: INDIA: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 85: INDIA: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 86: INDIA: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 87: JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 88: JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 89: JAPAN: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 90: JAPAN: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 91: JAPAN: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 92: ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 93: ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 94: ROAPAC: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 95: ROAPAC: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 96: ROAPAC: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 97: ROW: GENOMICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 98: ROW: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 99: ROW: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 100: ROW: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 101: ROW: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 102: ROW: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 103: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 104: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 105: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 106: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 107: MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 108: LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 109: LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 110: LATIN AMERICA: GENOMICS MARKET, BY PROCESS, 2015-2022 (USD MILLION)
  • TABLE 111: LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 112: LATIN AMERICA: GENOMICS MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL GENOMICS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: THE SERVICES SEGMENT IS EXPECTED TO REGISTER THE HIGHEST CAGR IN THE GLOBAL GENOMICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 9: THE PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL GENOMICS MARKET IN 2016
  • FIGURE 10: THE SEQUENCING SEGMENT IS EXPECTED TO REGISTER THE HIGHEST CAGR IN THE GLOBAL GENOMICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 11: THE DIAGNOSTICS SEGMENT IS EXPECTED TO REGISTER THE HIGHEST CAGR IN THE GLOBAL GENOMICS MARKET BETWEEN 2017 & 2022
  • FIGURE 12: THE RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES SEGMENT ACCOUNTED FOR LARGEST SHARE OF THE GLOBAL GENOMICS MARKET IN 2016
  • FIGURE 13: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL GENOMICS MARKET
  • FIGURE 14: RISING GOVERNMENT FUNDING FOR GENOMICS RESEARCH IS EXPECTED TO DRIVE THE GROWTH OF THE GENOMICS MARKET
  • FIGURE 15: CONSUMABLES SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 16: PCR (POLYMERASE CHAIN REACTION) TECHNOLOGY SEGMENT IS EXPECTED TO DOMINATE THE GENOMICS MARKET IN 2022
  • FIGURE 17: THE SEQUENCING SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 18: DIAGNOSTICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2022
  • FIGURE 19: NORTH AMERICA TO DOMINATE THE GENOMICS MARKET
  • FIGURE 20: NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 21: GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22: GENOMICS MARKET, BY PRODUCT AND SERVICE
  • FIGURE 23: GENOMICS MARKET, BY TECHNOLOGY
  • FIGURE 24: GENOMICS MARKET, BY PROCESS
  • FIGURE 25: DIAGNOSTICS SEGMENT TO HOLD LARGEST SHARE OF THE GENOMICS MARKET DURING 2017-2022
  • FIGURE 26: GENOMICS MARKET, BY END USER
  • FIGURE 27: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL GENOMICS MARKET IN 2017
  • FIGURE 28: NORTH AMERICA: GENOMICS MARKET SNAPSHOT
  • FIGURE 29: EUROPE: GENOMICS MARKET SNAPSHOT
  • FIGURE 30: ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
  • FIGURE 31: ROW: GENOMICS MARKET SNAPSHOT
  • FIGURE 32: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 33: ILLUMINA: COMPANY SNAPSHOT (2016)
  • FIGURE 34: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2016)
  • FIGURE 35: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 36: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 37: QIAGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 38: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 39: F. HOFFMANN-LA ROCHE : COMPANY SNAPSHOT (2016)
  • FIGURE 40: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 41: EPPENDORF: COMPANY SNAPSHOT (2016)
  • FIGURE 42: PACIFIC BIOSCIENCES OF CALIFORNIA: COMPANY SNAPSHOT (2016)
  • FIGURE 43: DANAHER : COMPANY SNAPSHOT (2016)
Back to Top